The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa.
Important notice regarding Rhopressa
![](https://floridasoptometry.gov/wp-content/themes/dohboards/img/divider.png)
Posted in Latest News on February 12, 2019.